Hasan, W., Chu, K., Gullapalli, A., Dunn, S.S., Enlow, E.M., Luft, J.C., Tian, S.M., Napier, M.E., Pohlhaus, P.D., Rolland, J.P. and DeSimone, J.M.(2012). Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer. Nano Letters, 12, 287-292.
http://dx.doi.org/10.1021/nl2035354

has been cited by the following article:

• TITLE: Prostate Cancer’s Molecular Imaging by Targeting Based Nanoparticles: An Overview

  AUTHORS: Hossein Heidari, Alireza Salehi Fordoei, Mostafa Saffary, Mehdi Shafiee Ardestani

  KEYWORDS: PLGA, Dendrimer, Nanoparticles Based Drug Delivery or Imaging Agents, Prostate Malignancies

  JOURNAL NAME: Health, Vol.7 No.5, May 20, 2015

  ABSTRACT: Today nanoparticles based drug delivery or imaging agents are extremely being investigated as a very powerful tool in early diagnostics or treatment of different kinds of cancers including prostate malignancies. Among the diverse developing nanomaterials, biocompatible biodegradable dendrimers and chitosan or PLGA (Poly Lactic-co-Glycolic Acid) derivatives are more considered due to their safer profiles. As a result, finding novel prostate imaging agents based on nano sized structures would be of high global interest which will be further discussed in this review.